Abbott Laboratories buy BTIG Research
Start price
16.10.25
/
50%
€110.96
Target price
16.10.26
€124.21
Performance (%)
-16.38%
Price
17:14
€92.78
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -16.38%. This prediction currently runs until 16.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 2.271% | 2.271% |
| iShares Core DAX® | 1.842% | 1.387% |
| iShares Nasdaq 100 | 4.659% | -1.797% |
| iShares Nikkei 225® | 3.963% | -5.216% |
| iShares S&P 500 | 3.700% | 1.576% |
Comments by BTIG_Research for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by BTIG_Research for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€77.70
27.04.26
27.04.26
€111.72
27.04.27
27.04.27
19.90%
17:14
17:14
Abbott Laboratories
Start price
Target price
Perf. (%)
€81.24
17.04.26
17.04.26
€111.25
17.04.27
17.04.27
14.67%
17:14
17:14
Abbott Laboratories
Start price
Target price
Perf. (%)
€95.00
18.02.26
18.02.26
€118.19
18.02.27
18.02.27
-1.94%
17:14
17:14
Abbott Laboratories
Start price
Target price
Perf. (%)
€107.90
20.11.25
20.11.25
€125.82
20.11.26
20.11.26
-13.66%
17:14
17:14
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
-15.71%
19.07.26
19.07.26